More on RNLXY
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.15 |
|
|||
| Open | $1.21 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.21 | ||||
| Day Low | $1.21 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 110 | ||||
- Renalytix™ and Carna Health Partner to Solve Kidney Disease Crisis: Bridging the Existing Gap Between Population Screening and Precision Intervention
- Form SCHEDULE 13D/A Renalytix plc Filed by: JEFFERSON RIVER CAPITAL LLC
- Form F-6 POS Renalytix plc Filed by: Citibank,N.A./ADR
- Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes
- Renalytix partners with Tempus AI to expand kidney disease testing
- Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease
- Form F-6 POS Renalytix plc Filed by: Citibank,N.A./ADR
- Form EFFECT Renalytix plc
- Form EFFECT Renalytix plc
- Form EFFECT Renalytix plc
Entities mentioned with RNLXY
- FDA | View Related Stories »
- 13G | View Related Stories »
- UBS | View Related Stories »
- NT 10-Q | View Related Stories »
- Stifel | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
